Press coverage about Danaher (NYSE:DHR) has trended somewhat positive on Thursday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Danaher earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned media coverage about the conglomerate an impact score of 46.6755382526604 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Shares of Danaher (NYSE:DHR) traded up $0.91 during trading on Thursday, reaching $97.01. 601,880 shares of the company were exchanged, compared to its average volume of 2,807,457. Danaher has a 12-month low of $78.97 and a 12-month high of $104.82. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39. The stock has a market cap of $67,310.00, a PE ratio of 27.73, a price-to-earnings-growth ratio of 2.00 and a beta of 1.04.
Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $1.16 by $0.03. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The firm had revenue of $5.09 billion for the quarter, compared to analyst estimates of $4.97 billion. During the same quarter in the previous year, the business posted $1.05 EPS. The firm’s revenue was up 10.9% compared to the same quarter last year. analysts predict that Danaher will post 4.37 earnings per share for the current year.
Several brokerages have recently issued reports on DHR. Barclays began coverage on shares of Danaher in a research note on Thursday. They set an “overweight” rating and a $110.00 price objective for the company. Royal Bank of Canada reissued a “hold” rating and set a $98.00 price objective on shares of Danaher in a research note on Wednesday, January 31st. Credit Suisse Group boosted their price objective on shares of Danaher from $99.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Stifel Nicolaus boosted their price objective on shares of Danaher from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Finally, Argus boosted their price objective on shares of Danaher from $100.00 to $115.00 and gave the company a “buy” rating in a research note on Thursday, February 1st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. Danaher presently has a consensus rating of “Buy” and a consensus target price of $100.68.
In other Danaher news, CFO Daniel L. Comas sold 62,989 shares of the business’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $101.96, for a total value of $6,422,358.44. Following the transaction, the chief financial officer now owns 227,805 shares in the company, valued at approximately $23,226,997.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Angela S. Lalor sold 42,988 shares of the business’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the completion of the transaction, the senior vice president now owns 82,008 shares in the company, valued at approximately $8,388,598.32. The disclosure for this sale can be found here. Insiders sold a total of 237,043 shares of company stock worth $24,194,886 in the last quarter. 12.20% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION NOTICE: This news story was originally published by Week Herald and is owned by of Week Herald. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://weekherald.com/2018/02/15/danaher-dhr-receives-media-impact-rating-of-0-22.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.